Searchable abstracts of presentations at key conferences in endocrinology

ea0096p21 | Section | UKINETS2023

The frequency of carcinoid heart disease in our neuroendocrine tumour cohort: a tertiary centre experience

Douglas Sasha , Batool Aaliya , Senthilvelavar Abishayini , Shah Tahir , Steeds Richard P

Introduction: Neuroendocrine tumours (NETs) can release harmful vasoactive substances into the systemic circulation, causing the characteristic features of carcinoid syndrome (CS) such as flushing, diarrhoea and bronchospasm. Approximately 20% of patients with CS develop carcinoid heart disease (CHD) due to progressive valve thickening, retraction and reduced mobility. CHD primarily affects the right-sided valves resulting in tricuspid and/or pulmonary regurgi...

ea0096p23 | Section | UKINETS2023

Reasons patients with carcinoid heart disease are deemed unfit for surgery: our tertiary centre experience

Douglas Sasha , Naneishvili Tamara , Yuan Mengshi , Muneeb Arshad Muhammad , Steeds Richard P

Introduction: Carcinoid heart disease (CHD) is a rare complication of neuroendocrine tumours (NETs) and carcinoid syndrome (CS). Approximately one in five patients with CS go on to develop CHD, which primarily affects the right side of the heart; leading to thickened, retracted, immobile and regurgitant cardiac valves that ultimately result in right ventricular (RV) dilatation and dysfunction 1 . Patients are referred for valve replacement if they have severe ...